Microcap Ledger Accuray Inc $ARAY
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Madison, WI
- Fiscal year end
- June 30
- Shares outstanding
- 119,439,307 [10-K 2026-08-27]
What the company doesAI summary of filing
Accuray Incorporated develops, manufactures, sells and supports radiation therapy systems for treating cancers, benign tumors, and selected neurological and endocrine disorders. The company's product portfolio includes the CyberKnife robotic radiation delivery platform and a helical portfolio consisting of Accuray Stellar, Radixact, Accuray Helix, and Tomo C systems, along with integrated treatment planning, imaging, and data management software. Accuray generates revenue by selling these radiation therapy systems and related services including customer support, installation, training, and professional services to hospitals and cancer treatment facilities in the United States and internationally. [10-K 2026-08-27]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| FY ended Jun 2026 | $401.95M | −$49.19M | −$6.98M | $40.62M | [10-K 2026-08-27] |
| FY ended Jun 2025 | $458.50M | −$1.59M | $2.86M | $57.42M | [10-K 2026-08-27] |
- Quarterly cash burn
- −$1.75M
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-01 | 100,565,016 | [10-Q 2024-11-06] |
| 2025-01-31 | 102,830,522 | [10-Q 2025-02-05] |
| 2025-04-30 | 103,013,384 | [10-Q 2025-05-02] |
| 2025-08-22 | 112,677,147 | [10-K 2025-08-28] |
| 2025-10-31 | 113,341,132 | [10-Q 2025-11-05] |
| 2026-01-30 | 118,782,630 | [10-Q 2026-02-17] |
| 2026-04-30 | 118,963,696 | [10-Q 2026-05-06] |
| 2026-08-21 | 119,439,307 | [10-K 2026-08-27] |
- Shelf registration
- S-3 filed 2026-07-31; declared effective 2026-09-11 [S-3 2026-07-31]
Listing status
Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-08-06. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-08-06 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-08-06] |
| 2026-02-06 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-02-06] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-23 | Pervaiz Ali | grant | 19,811 | — | [4 2026-10-01] |
| 2026-09-23 | Pervaiz Ali | other | 8,915 | $0.23 | [4 2026-10-01] |
| 2026-03-31 | Chalke Sandeep | other | 40,000 | $0.39 | [4 2026-04-01] |
| 2026-02-28 | Peralta Leonel | exercise | 83,723 | — | [4 2026-03-03] |
| 2026-02-28 | Peralta Leonel | other | 28,969 | $0.55 | [4 2026-03-03] |
| 2026-02-20 | Mayer Steven F | buy | 54,875 | $0.56 | [4 2026-02-23] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-06 | 8-K | Director or officer change; Shareholder vote results; Other events |
| 2026-09-11 | 424B3 | Prospectus or prospectus supplement |
| 2026-09-09 | S-3/A | Registration statement |
| 2026-09-02 | 13D/A | Beneficial ownership report (5%+ holder) |
| 2026-08-27 | 10-K | Annual report |
| 2026-08-24 | DEF 14A | Proxy statement |
| 2026-08-21 | S-3/A | Registration statement |
| 2026-08-19 | 8-K | Results of operations; Regulation FD disclosure |
| 2026-08-12 | PRE 14A | Proxy statement |
| 2026-08-06 | 8-K | Listing notice or transfer |
| 2026-08-05 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-07-31 | S-3 | Registration statement |
Alerts for $ARAY
Email me when Accuray Inc files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.